- Home
- BMRN vs BCH Comparison
BMRN vs BCH Comparison
Compare BMRN & BCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- BCH
- Stock Information
- Founded
- BMRN 1996
- BCH 1893
- Country
- BMRN United States
- BCH Chile
- Employees
- BMRN N/A
- BCH N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- BCH Commercial Banks
- Sector
- BMRN Health Care
- BCH Finance
- Exchange
- BMRN Nasdaq
- BCH Nasdaq
- Market Cap
- BMRN 12.1B
- BCH 13.1B
- IPO Year
- BMRN 1999
- BCH 2002
- Fundamental
- Price
- BMRN $59.82
- BCH $30.74
- Analyst Decision
- BMRN Buy
- BCH Hold
- Analyst Count
- BMRN 22
- BCH 1
- Target Price
- BMRN $93.43
- BCH $23.00
- AVG Volume (30 Days)
- BMRN 1.6M
- BCH 320.3K
- Earning Date
- BMRN 05-01-2025
- BCH 04-29-2025
- Dividend Yield
- BMRN N/A
- BCH 6.87%
- EPS Growth
- BMRN 152.82
- BCH N/A
- EPS
- BMRN 2.71
- BCH 0.01
- Revenue
- BMRN $2,950,227,000.00
- BCH $2,816,160,332.00
- Revenue This Year
- BMRN $12.27
- BCH $18.69
- Revenue Next Year
- BMRN $9.86
- BCH $5.24
- P/E Ratio
- BMRN $22.11
- BCH $11.94
- Revenue Growth
- BMRN 19.36
- BCH N/A
- 52 Week Low
- BMRN $52.93
- BCH $22.06
- 52 Week High
- BMRN $94.85
- BCH $30.83
- Technical
- Relative Strength Index (RSI)
- BMRN 40.34
- BCH 68.09
- Support Level
- BMRN $60.92
- BCH $29.12
- Resistance Level
- BMRN $65.40
- BCH $30.95
- Average True Range (ATR)
- BMRN 1.96
- BCH 0.69
- MACD
- BMRN 0.06
- BCH 0.08
- Stochastic Oscillator
- BMRN 21.52
- BCH 92.93
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.
About BCH Banco De Chile ADS
Operating under three separate brand names (Banco de Chile, Banco Edwards-Citi, and Banco CrediChile) Banco de Chile is the second largest in the country by loans and third largest by deposits. Banco de Chile generates most of its net interest income (roughly 60% of total revenue) from its mortgage, unsecured consumer credit lines, and commercial loans, with 25% of its outstanding loans being made to firms with more than 10,000 million CLP in revenue. Outside of its banking business, Banco de Chile is the largest asset manager in the country and one of the largest security brokerages, supporting its substantial fee-based revenue.